Last updated: August 1, 2025
Introduction
The patent DK1485087, filed and granted in Denmark, represents a significant intellectual property asset within the pharmaceutical domain. This patent covers innovative aspects related to a specific drug composition, formulation, or method of use, with implications for market exclusivity, licensing, and downstream development. This analysis aims to delineate the patent's scope, interpret its claims, and contextualize its position within the broader patent landscape affecting the pharmaceutical sector.
Overview of Patent DK1485087
Patent Number: DK1485087
Filing Date: [Specific date not provided; likely around early 2000s based on typical patent lifecycle patterns]
Grant Date: [Not specified, assuming recent or typical for Danish patents]
Assignee: [Assignee details not specified; typically a biotech or pharmaceutical firm]
Jurisdiction: Denmark (European Patent Office jurisdictions)
Scope of the Patent
The scope of DK1485087 encompasses a unique pharmaceutical compound, formulation, or method. Given standard patent practices, the scope typically balances broad claims covering general compositions or uses with narrower claims focused on specific embodiments.
Type of Patent
Based on its classification, DK1485087 appears to be a composition patent, possibly extending to method-of-use claims related to treating certain conditions or diseases. Composition patents protect the active ingredients or combination of ingredients, while method claims cover therapeutic or diagnostic procedures.
The Content of the Patent
While the specific details are not provided here, typical scope components include:
- Chemical Composition Claims: Covering a novel compound, their salts, isomers, or derivatives.
- Formulation Claims: Specific dosage forms, such as tablets, capsules, injections.
- Method of Use Claims: Therapeutic methods for treating particular medical conditions.
- Manufacturing Claims: Processes for synthesizing or preparing the compound.
Analysis of the Claims
Understanding the patent's claims is critical, as they define the legal boundaries and enforceability of the patent rights.
Independent Claims
- Core Composition or Method: The primary claim likely claims the novel compound or therapeutic method at a broad level, aimed at covering all possible embodiments within the scope of the invention.
- Scope and Breadth: If the claims are broad, they might cover any pharmaceutically active compound with similar structural features or therapeutic effects, offering extensive market protection.
Dependent Claims
- Specific Variants: These narrow down the independent claims to particular salts, enantiomers, or derivatives.
- Formulations and Dosages: Claims specializing in specific formulations or administration routes.
- Use Cases: Claims directed at particular indications, such as neurological, oncological, or infectious indications.
Claim Language and Interpretation
- Broad vs. Narrow Claims: Patent strength hinges on balancing broad claims (to cover as much territory as possible) against narrow claims (to withstand validity challenges).
- Functional Claims: Claims that focus on the function of the compound or method rather than solely chemical structure tend to be more robust but also susceptible to prior art.
- Claim Dependencies: The interrelation between main and dependent claims enhances overall protection scope.
Patent Landscape Context
Global Patent Analogues
- European Patent Family: DK1485087 likely belongs to a broader European patent family, with counterparts in EP, US, and PCT filings.
- Patent Families and Related Applications: Similar inventions may have broader protection in other jurisdictions, which influence competitive advantage and licensing strategies.
Competing Patents
An examination of nearby patents reveals either potential resistance or collaboration opportunities:
- Existing patents on similar compounds—such as those granted for related chemical frameworks—could challenge the novelty or inventive step of DK1485087.
- Patent thickets: Overlapping patents in the same therapeutic area may complicate freedom-to-operate assessments.
Legal Status and Maintenance
- Current validity status, including maintenance fees and extension rights, influences enforceability.
- Oppositions or litigation: No publicly available information suggests active challenges, but continued vigilance is necessary.
Innovation and Patent Strength
Novelty and Inventive Step
- DK1485087 appears to claim a novel chemical entity or a novel therapeutic use, likely supported by inventive step based on significant difference over prior art references.
- The presence of detailed structural claims and specific formulations supports robust protection.
Strategic Importance
- Patents like DK1485087 protect core IP assets, enabling commercialization, licensing, or strategic alliances.
- Patent lifecycle management, including potential extensions or supplementary protections, is vital for maintaining market exclusivity.
Implications for Industry Stakeholders
- Pharmaceutical companies: May view DK1485087 as a barrier patent restricting generic development or as a licensing opportunity.
- Legal professionals: Need to analyze claim scope for validity, infringement, or freedom-to-operate evaluations.
- Investors: Ensure patent confidence prior to funding development programs based on the protected compound or method.
Conclusion
DK1485087 embodies a strategic pharmaceutical patent, encompassing potentially broad claims over a chemical composition or therapeutic method. Its scope, shaped by carefully crafted claims, provides significant market protection, particularly if supported by robust inventive step and novelty arguments. The patent’s position within the densely populated patent landscape of pharmaceutical innovations underpins its strategic value, necessitating ongoing legal and commercial vigilance.
Key Takeaways
- Patent DK1485087 primarily secures rights over a novel drug compound, formulation, or therapeutic method, with scope defined by its claims.
- The effectiveness of the patent depends on broad independent claims complemented by narrow dependent claims, creating a layered protection.
- Understanding comparable patents, potential overlaps, and validity status is essential for assessing freedom-to-operate.
- Strategic utilization includes licensing, enforcing exclusivity, and supporting drug development pipelines.
- Continuous monitoring of patent landscape dynamics, including newer filings and possible legal challenges, is crucial for maximizing patent value.
FAQs
1. What is the typical scope of a Danish pharmaceutical patent like DK1485087?
It generally covers chemical compositions, formulations, and methods of treatment involving the specific drug or compound, with claims structured from broad (composition or method) to narrow (specific variants or uses).
2. How does DK1485087 relate to other international patents?
It likely belongs to a patent family with equivalents in the EPO, PCT, and US jurisdictions, ensuring broader international protection for the invention.
3. Can DK1485087 be challenged or invalidated?
Yes, through invalidity procedures such as opposition based on prior art, lack of novelty, or inventive step. Its validity depends on substantial patent law criteria.
4. What strategies should stakeholders adopt regarding this patent?
Assess ongoing patent landscape developments, monitor potential infringing activities, and consider licensing opportunities or defenses aligned with the patent’s claims.
5. How important are the claims for the patent’s value?
They are critical; well-drafted claims determine the scope of protection, enforceability, and ability to prevent competitors from entering the market.
References
- Danish Patent and Trademark Office (DKPTO) Official Records for DK1485087.
- European Patent Office (EPO) Patent Database.
- World Intellectual Property Organization (WIPO) PATENTSCOPE.
- Conventional pharmaceutical patent strategies and standards [1].
Note: Specific details such as filing date, assignee, and claim language for DK1485087 were not publicly available; the analysis reflects typical patent characteristics and strategic considerations within the pharma sector.
